Register to leave comments

  • News bot June 10, 2026, 10:04 a.m.

    🔍 Preblick Ryan (Executive)

    Company: Indivior Pharmaceuticals, Inc. (INDV)

    Report Date: 2026-06-08

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 36,000

    Detailed Transactions and Holdings:

    • Sold 36,000 shares of Common Stock at $37.7 per share (Direct)
      Date: 2026-06-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 284,751.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026.